March 28, 2019
Within the last few years the FDA has undergone a metamorphosis when it comes to digital health regulations. Though many of these are not yet solidified, a recent report by PricewaterhouseCoopers (PwC) predicts that these changes could open new doors for pharmaceutical companies looking to jump into the digital arena.
“Changes made by the FDA have made it easier for digital health products to be...
September 1, 2016
Physicians are up to their ears in information, eager for new, technologically advanced solutions, and struggling to keep up with healthcare reform. At least, that’s the sense researchers from the Decision Resource Group got from a recent survey of doctors.
For the study, Taking the Pulse, the group surveyed 2,994 US physicians, finding that – in an era of a collective shift towards value rather...
April 24, 2013
Treato, an Israeli company that scours thousands of social media sites to glean patient insights about pharmaceuticals and treatments, has landed $14.5 million in new capital. OrbiMed Israel Partners and New Leaf Venture Partners led the round of funding, which also included previous investors Reed Elsevier Ventures and Western Technology Investments, the company says.
Treato, of Yehud, Israel,...
January 12, 2010
Pharmaceutical giant Novartis announced that would invest $24M in upfront cash and equity as part of an exclusive worldwide agreement for the pharma company to license Proteus Biomedical's sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot last year.)
As part of the deal,...
November 2, 2009
As we hinted last week, Wireless sensor and neuropathology start-up NeuroVigil has inked a deal with Swiss pharamceutical company Roche. NeuroVigil will provide Roche with its iBrain wireless sensors to help the company collect and analyze data during its clinical trials. NeuroVigil technology will be used to help the company's development of various drugs for CNS disorders. The iBrain devices...
September 22, 2009
Pharmaceutical giant Novartis has tapped intelligent medicine start-up Proteus Biomedical for a small 20 patient study to track patients' compliance with their blood pressure drug regimen. The patients are taking blood pressure drug Diovan and the study organizers track their compliance via Proteus' "chip in the pill" technology, which reports to a receiver sensor on the patient's shoulder when...